Elevated serum eotaxin and IP‐10 levels as potential biomarkers for the detection of esophageal squamous cell carcinoma-Reference-Cited by-同舟云学术

Elevated serum eotaxin and IP‐10 levels as potential biomarkers for the detection of esophageal squamous cell carcinoma

Published:2021-07-21 Issue:9 Volume:35 Page:
ISSN:0887-8013
Container-title:Journal of Clinical Laboratory Analysis
language:en
Short-container-title:J Clin Lab Anal

Author:

Chang Chen¹,Wang Min‐Jie²,Bi Xiao‐Feng³,Fan Zhi‐Yuan⁴,Feng Dan¹,Cai Hong‐Qing¹,Zhang Yu¹,Xu Xin¹,Cai Yan¹,Qi Jun²,Wei Wen‐Qiang⁴,Hao Jia‐Jie¹,Wang Ming‐Rong¹^ORCID

Affiliation:

1. State Key Laboratory of Molecular Oncology Center for Cancer Precision Medicine National Cancer Center/National Clinical Research Center for Cancer/Cancer HospitalChinese Academy of Medical Sciences and Peking Union Medical College Beijing China

2. Department of Clinical Laboratory National Cancer Center/National Clinical Research Center for Cancer/Cancer HospitalChinese Academy of Medical Sciences and Peking Union Medical College Beijing China

3. Department of Cancer Prevention Office of Cancer Screening National Cancer Center/National Clinical Research Center for Cancer/Cancer HospitalChinese Academy of Medical Sciences and Peking Union Medical College Beijing China

4. Department of Cancer Epidemiology Center for Cancer Precision Medicine National Cancer Center/National Clinical Research Center for Cancer/Cancer HospitalChinese Academy of Medical Sciences and Peking Union Medical College Beijing China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Microbiology (medical),Biochemistry (medical),Medical Laboratory Technology,Clinical Biochemistry,Public Health, Environmental and Occupational Health,Hematology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcla.23904

Reference37 articles.

1. Oesophageal carcinoma

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

3. Serum Biomarkers for the Prediction of Hepatocellular Carcinoma

4. Cancer testis antigen SPAG9 is a promising marker for the diagnosis and treatment of lung cancer

5. Validation of Prognosis Value of Cumulative Prognostic Scores Based on Serum High-Density Lipoprotein Cholesterol and Albumin Levels in Patients with Colorectal Cancer

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differences in Eotaxin Serum Levels between Polytraumatized Patients with and without Concomitant Traumatic Brain Injury—A Matched Pair Analysis;Journal of Clinical Medicine;2024-07-19

2. The effect of acute acid exposure on immunomodulatory protein secretion, cell survival, and cell cycle progression in tumour cell lines;Cytokine;2023-02

3. Importance of IP-10 as a biomarker of host immune response: Critical perspective as a target for biosensing;Current Research in Biotechnology;2023

4. The Diagnostic Value of Serum Ang, VEGF, and CRP Combined with the Chinese Medicine Antitumor Formula in the Treatment of Advanced Renal Carcinoma;Evidence-Based Complementary and Alternative Medicine;2021-12-14